Use of fibrin-based sealants and gelatin-matrix hemostats in laparoscopic liver surgery

Surgical Laparoscopy, Endoscopy and Percutaneous Techniques

Volumn 21, Issue 3, 2011, Pages 131-141

  Saif, Rehan ^a   Robinson, Stuart ^a   Amer, Amien ^a   Kei Hui, Douglas ^a   Sen, Gourab ^a   Manas, Derek ^a   White, Steve ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Fibrin glue; Hemostat; Laparoscopic surgery; Liver surgery; Sealant

Indexed keywords

ALBUMIN; AMINE; APROTININ; BOVINE SERUM ALBUMIN; CELLULOSE; COLLAGEN; CYANOACRYLATE DERIVATIVE; CYANOACRYLIC ACID OCTYL ESTER; FIBRIN GLUE; FIBRINOGEN; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; GELATIN; GELATIN MATRIX BASED HEMOSTATIC AGENT; GLUTARALDEHYDE; HEMOSTATIC AGENT; INORGANIC COMPOUND; IRINOTECAN; MACROGOL; OXALIPLATIN; PLASMINOGEN; POLYACRYLIC ACID; POLYSACCHARIDE; SILICON DIOXIDE; TACHOCOMB; THROMBIN; TRANEXAMIC ACID; TRILISINE AMINE; UNCLASSIFIED DRUG; ZEOLITE;

ARGON PLASMA COAGULATION; BLEEDING; DATA BASE; FATTY LIVER; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC LIVER SURGERY; LAPAROSCOPIC SURGERY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER INJURY; LIVER METASTASIS; LIVER RESECTION; LIVER SURGERY; LIVER TUMOR; MEDICAL LITERATURE; META ANALYSIS; PLASMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINUSOIDAL OBSTRUCTION SYNDROME; SUTURING METHOD; SYSTEMATIC REVIEW;

ADMINISTRATION, TOPICAL; BIOCOMPATIBLE MATERIALS; BLOOD LOSS, SURGICAL; DRUG COMBINATIONS; FIBRIN TISSUE ADHESIVE; FIBRINOGEN; HEMOSTATIC TECHNIQUES; HEMOSTATICS; HEPATECTOMY; HUMANS; LAPAROSCOPY; LIVER DISEASES; SURGICAL SPONGES; THROMBIN; TREATMENT OUTCOME;

EID: 80051913362     PISSN: 15304515     EISSN: 15344908     Source Type: Journal    
DOI: 10.1097/SLE.0b013e31821db688     Document Type: Review

References (76)

1. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in peri-operative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg. 2002;236: 397-406.
2. Seyednejad H, Imani M, Jamieson T, et al. Topical haemostatic agents. Br J Surg. 2008;95:1197-1225.
3. Spotnitz WD, Burks S. Hemostats, sealants, and adhesives: components of the surgical toolbox. Transfusion. 2008;48: 1502-1516.
4. Rogula T, Gagner M. Current status of the laparoscopic approach to liver resection. J Long Term Eff Med Implants. 2004;14:23-31. (Pubitemid 38404948)
5. Koffron A, Geller D, Gamblin TC, et al. Laparoscopic liver surgery: shifting the management of liver tumours. Hepatology. 2006;44:1694-1700. (Pubitemid 44953676)
6. Morino M, Morra I, Rosso E, et al. Laparoscopic versus open hepatic resection: a comparative study. Surg Endosc. 2003;17:1914-1918. (Pubitemid 38049902)
7. Simillis C, Constantinides VA, Tekkis PP, et al. Laparoscopic versus open hepatic resections for benign and malignant neoplasms - a meta-analysis. Surgery. 2007;141:203-211.
8. Melman L, Matthews BD. Current trends in laparoscopic solid organ surgery: spleen, adrenal, pancreas, and liver. Surg Clin North Am. 2008;88:1033-1046.
9. Yoshida H, Hirozane K, Kamiya A. Adhesive strength of autologous fibrin glue. Biol Pharm Bul. 2000;23:313-317. (Pubitemid 30187277)
10. Stanek G, Bosch P, Weber P. Comparison of growth of Staphylococcus aureus in a fibrin-clotting system and in clotted blood-a quantitative investigation (author's translation). Zen-tralbl Bakteriol [Orig A]. 1978;240:441-446. (Pubitemid 8388322)
11. Horowitz B, Busch M. Estimating the pathogen safety of manufactured human plasma products: application to fibrin sealants and to thrombin. Transfusion. 2008;48:1739-1753.
12. Hino M, Ishiko O, Honda KI, et al. Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery. Br J Haematol. 2000;108:194-195. (Pubitemid 30089954)
13. Kawamura M, Sawafuji M, Watanabe M, et al. Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery. Ann Thorac Surg. 2002;73:1098-1100. (Pubitemid 34275886)
14. Banninger H, Hardegger T, Tobler A, et al. Fibrin glue in surgery: frequent development of inhibitors of bovine throm-bin and human factor V. Br J Haematol. 1993;85:528-532. (Pubitemid 23349056)
15. Sarfat MR, DiLorenzo DJ, Kraiss LW, et al. Severe coagulopathy following intraoperative use of topical thrombin. Ann Vasc Surg. 2004;18:349-351. (Pubitemid 38691569)
16. Crow SS, Sullivan VV, Ayosola AE, et al. Postoperative coagulopathy in a pediatric patient after exposure to bovine thrombin. Ann Thorac Surg. 2007;83:1547-1549. (Pubitemid 46440760)
17. Oz MC, Rondinone JF, Shargill NS. Floseal matrix: new generation topical hemostatic sealant. J Card Surg. 2003;18: 486-493. (Pubitemid 37476111)
18. Renkens KL Jr, Payner TD, Leipzig TJ, et al. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine. 2001;26:1645-1650. (Pubitemid 32756652)
19. Oz MC, Cosgrove DM III, Badduke BR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. Ann Thorac Surg. 2000;69:1376-1382. (Pubitemid 30434861)
20. Alfieri S, Di Miceli D, Ridolfini MP, et al. The role of oxidized regenerated cellulose in preventing surgical site infections: a randomized prospective study on 49 patients with "dirty" surgical wounds. Osp Ital Chir. 2007;13:176-183.
21. Heaton N. Advances and methods in liver surgery: haemos-tasis. Eur J Gastroenterol Hepatol. 2005;17(suppl 1):S3-S12.
22. Wright JK, Kalns J, Wolf EA, et al. Thermal injury resulting from application of a granular mineral hemostatic agent. J Trauma. 2004;57:224-230. (Pubitemid 39166769)
23. Senzolo M, Burra P, Cholongitas E, et al. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol. 2006;12:7725-7736. (Pubitemid 46099938)
24. Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065-2072. (Pubitemid 46622116)
25. Khan AZ, Morris-Stiff G, Makuuchi M. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver meta-stases. J Hepatobiliary Pancreat Surg. 2009;16:137-144.
26. Jabbour N, Gagandeep S, Mateo R, et al. Liver donor liver transplantation without blood products. Strategies developed for Jehovah's Witnesses offer broad application. Ann Surg. 2004;240:350-357. (Pubitemid 38963028)
27. Katkhouda N. New hemostatic agents in general open and laparoscopic surgery. Surg Technol Int. 2004;13:65-70.
28. Poon RT. Recent advances in techniques of liver resection. Surg Technol Int. 2004;13:71-77.
29. Lesurtel M, Selzner M, Petrowsky H, et al. How should transection of the liver be performed?: a prospective randomized study in 100 consecutive patients: comparing four different transection strategies. Ann Surg. 2005;242:814-822.
30. Takayama T, Makuuchi M, Kubota K, et al. Randomized comparison of ultrasonic versus clamp transection of the liver. Arch Surg. 2001;136:922-928. (Pubitemid 32729553)
31. Lattouf JB, Beri A, Klinger CH, et al. Practical hints for hemostasis in laparoscopic surgery. Minim Invasive Ther Allied Technol. 2007;16:45-51. (Pubitemid 46322913)
32. Kretzschmar M, Kruger A, Schirrmeister W. Hepatic ischemia-reperfusion syndrome after partial liver resection (LR): hepatic venous oxygen saturation, enzyme pattern, reduced and oxidized glutathione, procalcitonin and interleukin-6. Exp Toxicol Pathol. 2003;54:423-431. (Pubitemid 36841188)
33. Garcea G, Gescher A, Steward W, et al. Oxidative stress in humans following the Pringle manoeuvre. Hepatobiliary Pancreat Dis Int. 2006;5:210-214. (Pubitemid 43826909)
34. Chouker A, Schachtner T, Schauer R, et al. Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. Br J Anaesth. 2004;9:204-211. (Pubitemid 39117395)
35. van der Bilt JD, Soeters ME, Duyverman AM, et al. Perinecrotic hypoxia contributes to ischemia/reperfusion-ac-celerated outgrowth of colorectal micrometastases. Am J Pathol. 2007;170:1379-1388. (Pubitemid 47339344)
36. Berrevoet F, de Hemptinne B. Clinical application of topical sealants in liver surgery: does it work?. Acta Chir Belg. 2007;107:504-507.
37. Berrevoet F, de Hemptinne B. Use of topical hemostatic agents during liver resection. Dig Surg. 2007;24:288-293. (Pubitemid 47174045)
38. Sarpel U, Roayaie S, Schwartz ME, et al. The role of fibrin sealants in hepatic surgery. Surg Technol Int. 2007;16:31-36.
39. Kohno H, Nagasue N, Chang YC, et al. Comparison of topical hemostatic agents in elective hepatic resection: a clinical prospective randomized trial. World J Surg. 1992;16:966-969.
40. Noun R, Elias D, Balladur P, et al. Fibrin glue effectiveness and tolerance after elective liver resection: a randomized trial. Hepatogastroenterology. 1996;43:221-224. (Pubitemid 26083788)
41. Eder F, Meyer F, Nestler G, et al. Sealing of the hepatic resection area using fibrin glue reduces significant amount of postoperative drain fluid. World J Gastroenterol. 2005;11: 5984-5987. (Pubitemid 41749212)
42. Chapman WC, Clavien PA, Fung J, et al. Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma: results of a randomized controlled trial. Arch Surg. 2000;135:1200-1204.
43. Schwartz M, Madriaga J, Hirose R, et al. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg. 2004;139:1148-1154. (Pubitemid 39463445)
44. Frilling A, Stavrou GA, Mischinger HJ, et al. Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Langenbecks Arch Surg. 2005;390:114-120. (Pubitemid 40487434)
45. Figueras J, Llado L, Miro M, et al. Application of fibrin glue sealant after hepatectomy does not seem justified: results of a randomized study in 300 patients. Ann Surg. 2007;245:536-542 (Pubitemid 46555656)
46. Costasis Multi-center Collaborative Writing Committee. A novel collagen-based composite offers effective hemostasis for multiple surgical indications: results of a randomized controlled trial. Surgery. 2001;129:445-450.
47. Katkhouda N. Application of fibrin glue after hepatectomy might still be justified. Ann Surg. 2008;247:399-400; author reply 400. (Pubitemid 351156799)
48. Nakajima Y, Shimamura T, Kamiyama T, et al. Control of intra-operative bleeding during liver resection: analysis of a questionnaire sent to 231 Japanese hospitals. Surg Today. 2002;32:48-52. (Pubitemid 34119046)
49. Klemcke HG. Evaluation of FloSeal as a potential intracavi-tary hemostatic agent. J Trauma. 2006;60:385-389.
50. Leixnering M, Reichetseder J, Schultz A, et al. Gelatin thrombin granules for hemostasis in a severe traumatic liver and spleen rupture model in swine. J Trauma. 2008;64:456-461. (Pubitemid 351640462)
51. Izzo F, Di Giacomo R, Falco P, et al. Efficacy of a haemostatic matrix for the management of bleeding in patients undergoing liver resection: results from 237 cases. Curr Med Res Opin. 2008;24:1011-1015. (Pubitemid 351579157)
52. Kim FJ, Chammas MF Jr, Gewehr E, et al. Temperature safety profile of laparoscopic devices: Harmonic ACE (ACE), Ligasure V (LV) and plasma trisector (PT). Surg Endosc. 2008;22:1464-1469.
53. Msezane LP, Katz MH, Gofrit ON, et al. Hemostatic agents and instruments in laparoscopic renal surgery. J Endourol. 2008;22:403-408. (Pubitemid 351430737)
54. Fatal gas embolism caused by overpressurization during laparoscopic use of argon enhanced coagulation. Health Devices. 1994;23:257-259.
55. Shanberg AM, Zagnoev M, Clougherty TP. Tension pneu-mothorax caused by the argon beam coagulator during laparoscopic partial nephrectomy. J Urol. 2002;168:2162.
56. Min SK, Kim JH, Lee SY. Carbon dioxide and argon gas embolism during laparoscopic hepatic resection. Acta Anaes-thesiol Scand. 2007;51:949-953. (Pubitemid 47063012)
57. Ikegami T, Shimada M, Imura S, et al. Argon gas embolism in the application of laparoscopic microwave coagulation therapy. J Hepatobiliary Pancreat Surg. 2009;16:394-398.
58. Saxton ML. Hemostasis in minimally invasive liver surgery. Surgery. 2007;142(suppl 4):S46-S49.
59. Koffron AJ, Auffenberg G, Kung R, et al. Evaluation of 300 minimally invasive liver resections at a single institution: less is more. Ann Surg. 2007;246:385-394.
60. Figueredo EJ, Yeung RS. Laparoscopic liver resection. Medscape J Med. 2008;10:68.
61. Abu Hilal M, Pearce NW. Laparoscopic left lateral liver sectionectomy: a safe, efficient, reproducible technique. Dig Surg. 2008;25:305-308.
62. Morino M, Morra I, Miglietta C, et al. Laparoscopic versus open hepatic resection. Surg Endosc. 2003;17:1914-1918. (Pubitemid 38049902)
63. Alkari B, Owera A, Ammori B. Laparoscopic liver resection: preliminary results from a UK centre. Surg Endosc. 2008;22: 2201-2207.
64. Lai E, Tang C, Yang G, et al. Minimally invasive surgical treatment of hepatocellular carcinoma: long-term outcome. World J Surg. 2009;33:2150-2154.
65. Cho J, Han H, Yoon Y, et al. Experiences of laparoscopic liver resection including lesions in the posterosuperior segments of the liver. Surg Endosc. 2008;22:2344-2349.
66. Cho J, Han H, Yoon Y, et al. Outcomes of laparoscopic liver resection for lesions located in the right side of the liver. Arch Surg. 2009;144:25-29.
67. Wang E, Kow A, Chan C, et al. Starting a laparoscopic hepatectomy programme. Singapore Med J. 2009;50:354-359.
68. Patriti A, Ceccarelli G, Bartoli A, et al. Laparoscopic and robot-assisted one-stage resection of colorectal cancer with synchronous liver metastases: a pilot study. J Hepatobiliary Pancreat Surg. 2009;16:450-457.
69. Albeniz Arbizu E, Lopez San Roman A, Garcia Gonzalez M, et al. Fibrin-gel sealed liver biopsy in patients with a liver transplantation or in liver transplantation waiting list: preliminary results. Transplant Proc. 2003;35:1911-1912. (Pubitemid 37093761)
70. Saxena AK, van Tuil C. Advantages of fibrin glue spray in laparoscopic liver biopsies. Surg Laparosc Endosc Percutan Tech. 2007;17:545-547.
71. Robinson S, Manas D, Noormohamed S, et al. The use of an impregnated collagen sponge (tachosil) for laparoscopic radiofrequency ablation of liver tumours. HPB. 2009;11(suppl 2):150.
72. Lochan R, French J, Robinson S, et al. A new duplocath MIS system (minimally invasive system) to facilitate pancreatic stump management during laparoscopic distal pancreatect-omy. HPB. 2009;11(suppl 2):157.
73. Kheirabadi BS, Sieber J, Bukhari T, et al. High-pressure fibrin sealant foam: an effective hemostatic agent for treating severe parenchymal hemorrhage. J Surg Res. 2008;144:145-150. (Pubitemid 350234947)
74. Wong C, Inman E, Spaethe R, et al. Fibrin-based biomaterials to deliver human growth factors. Thromb Haemost. 2003;89:573-582. (Pubitemid 36329250)
75. Jeon O, Ryu SH, Chung JH, et al. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J Control Release. 2005;105:249-259. (Pubitemid 40941990)
76. Michlits W, Mittermayr R, Schafer R, et al. Fibrin-embedded administration of VEGF plasmid enhances skin flap survival. Wound Repair Regen. 2007;15:360-367. (Pubitemid 46817412)